Filing Details
- Accession Number:
- 0000899243-18-026072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-03 17:21:46
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-03 17:21:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1655759 | Arvinas Inc. | ARVN | Pharmaceutical Preparations (2834) | 472566120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1753491 | Albert Bradley Margus | C/O Arvinas, Inc. 5 Science Park, 395 Winchester Ave. New Haven CT 06511 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-01 | 40,000 | $16.00 | 99,463 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-10-01 | 42,768 | $0.00 | 42,768 | No | 4 | C | Indirect | By Bradley A. Margus Revocable Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Indirect | By Bradley A. Margus Revocable Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2018-10-01 | 120,055 | $0.00 | 36,940 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2018-10-01 | 18,942 | $0.00 | 5,828 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering.
- On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.